Study: osteoporosis can be useful for the elderly

Researchers during a meeting of the endocrine association in the US city of San Francisco, that elderly people who have the age of eighty fractures benefit from the medicine for erosion or bone weakness as a result of fragility. A controversy occurred about taking osteoporosis at this age, for fear that patients of the elderly will be more likely to have side effects. Researchers from Cleveland Clinic assessed the medical records of a total of 88 thousand and 676 patients of 80 years or longer and had fractions due to osteoporosis. Half of the patients later became the drug “Fosamax” produced by the company “Merck & Co”, the drug “Buniva” of “Roche”, “GlaxoSmith Klein” or a prolacti from “Prison”, or “Evsta” or “Fortio”, which was later produced by “Eli Lily”. Over the next five years, and after taking into account the other health conditions of patients, the hospital’s access rate fell by 19% and the death rate fell by 15% in the group receiving medication for bone reinforcement. “The results of our study support the need to encourage the beginning of receiving osteoporosis treatments based on the terms of each case, even for people older than 80 years,” says Dr. Gianna Flaco, who led the study in a statement. She added: “Treating people to reduce the burden of osteoporosis complications such as fractions leading to disability or death would play an important role in improving public health among individuals whose numbers are increasing.”